Shockwave Medical, Inc. acquired NEOVASC Neovasc’s Innovative Reducer System Will Target the Estimated

Shockwave Medical, Inc. -> NEOVASC Neovasc’s Innovative Reducer System Will Target the Estimated · $27.25

We believe the Reducer is an excellent fit for Shockwave as it enables us to apply our capabilities to address another large, unmet need within cardiology – refractory angina,” said Doug Godshall, President and Chief Executive Officer of Shockwave.